ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and ...
ImmunoPrecise Antibodies Ltd., an AI-powered antibody company, has partnered with RIBOPRO, a technology provider specializing ...
There's nothing swampier than handing over billions of taxpayer dollars to a pharmaceutical company that had already gotten rich off the coronavirus pandemic.
When people undergo radiotherapy for cancer, it's not just the tumor that suffers. The radiation causes DNA breaks in healthy ...
This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.
Generation Bio (NASDAQ:GBIO – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Wednesday, March 5th. Analysts expect Generation Bio to post earnings of ...
About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...
YolTech Therapeutics reports positive clinical data for YOLT-203, an in vivo gene editing therapy for primary hyperoxaluria type 1: Shanghai, China Wednesday, February 26, 2025, 1 ...
Daily Wrap on MSN53m
Tardigrade superpowers: Shielding healthy cells from radiotherapyTardigrades, microscopic organisms renowned for their extraordinary resistance to radiation, may offer a means to protect ...
18h
Investing News Network on MSNStem Cell Stocks: 10 Biggest NASDAQ Companies in 2025Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...
Following these changes, the company has also seen the addition of four new directors * Robert Alan Beardsley, Joseph Bishop, ...
18hon MSN
In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results